NCT06092424进行中（未招募）不适用
Comparative Study of Pulmonary Artery Pressure (PAP) and Other Hemodynamics Assessed by Echocardiography in Patients With Pulmonary Vascular Diseases Permanently Residing Above 2500 Meters When Assessed Near Resident High Altitude (HA) at 2840m vs. at Low Altitude (LA) Sea Level
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 36
- 试验地点
- 2
- 主要终点
- Pulmonary artery Pressure (PAP) in the morning of second day at sea level (LA)
研究概览
简要总结
To study the effect of relocation from 2840m (Quito) to sea level (Pedernales) in patients with pulmonary vascular diseases (PVD) defined as pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension (PH) who permanently live >2500m on pulmonary artery pressure (PAP) and other hemodynamics.
详细描述
This research in patients with PVD diagnosed with precapillary PH with right heart catheterization and classified to groups 1 and 4 (PAH or CTEPH) who permanently live at HA >2500 (PVD_HA) will have PAP and other hemodynamics assessed by echocardiography and blood gases near their living altitude in Quito at 2840m and at sea level in Pedernales the day after the first and the second night after relocation.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Crossover
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 90 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult patients 18-90 years old of both genders,
- •Residence > 2500m of altitude
- •diagnosed with precapillary PH (mean pulmonary artery pressure (mPAP) >20 mmHg, pulmonary artery wedge pressure (PAWP) ≤15 mmHg and pulmonary vascular resistance (PVR) ≥2 wood units (WU) by right heart catheterization) with PH being classified as PAH or CTEPH according to guidelines
- •Patients stable on therapy
- •New York Heart Association (NYHA) functional class I-III
- •Provided written informed consent to participate in the study.
排除标准
- •Age <18 years or >80 years
- •unstable condition
- •Patients who cannot follow the study investigations, patient permanently living < 2500m.
- •Patients with moderate to severe concomitant lung disease (FEV1<70% or forced vital capacity <70%), severe parenchymal lung disease, severe smokers (>20 cigarettes/day)
- •Severely hypoxemic patients at Quito permanently have persistent oxygen saturation by pulse-oximetry (SpO2) <80% on ambient air.
- •Patients with chronic mountain sickness (Hemoglobin > 19 g/dl in women, >21 g/dl in men)
- •Patient with a non-corrected ventricular septum defect
- •Relevant concomitant other disease of the heart, kidney, liver, blood (anemia hemoglobin<11 g/dl)
结局指标
主要结局
Pulmonary artery Pressure (PAP) in the morning of second day at sea level (LA)
时间窗: in the morning of the second day at sea level
Change in PAP in mmHg assessed by echocardiography between LA (sea level) vs High altitude (HA)
次要结局
- Tricuspid pressure gradient by echocardiography in the morning of the second day at sea level(in the morning of the second day at sea level)
- Tricuspid pressure gradient by echocardiography in the morning of the third day at sea level(in the morning of the third day at sea level)
- Cardiac output in the morning of the second day at sea level(in the morning of the second day at sea level)
- Cardiac output in the morning of the third day at sea level(in the morning of the third day at sea level)
- Tricupsid annular plane systolic excursion by echocardiography in the morning of the second day at sea level(in the morning of the third day at sea level)
- Tricupsid annular plane systolic excursion by echocardiography in the morning of the third day at sea level(in the morning of the third day at sea level)
- ph by arterial blood gases in the morning of the second day at sea level(in the morning of the second day at sea level)
- partial pressure of oxygen (PaO2) by arterial blood gases in the morning of the second day at sea level(in the morning of the second day at sea level)
- partial pressure of carbon dioxide (PaCO2) by arterial blood gases in the morning of the second day at sea level(in the morning of the second day at sea level)
研究者
研究点 (2)
Loading locations...
相似试验
进行中（未招募）
不适用
HA Residents With PVD, 6MWD Assessed at HA (2840m) vs LA (Sea Level)Pulmonary Vascular DiseasePulmonary Artery HypertensionChronic Thromboembolic Pulmonary HypertensionNCT05996302University of Zurich24
已完成
不适用
High Altitude (HA) Residents With High Altitude Pulmonary Hypertension (HAPH), Pulmonary Artery Pressure (PAP) Assessed at HA (3200 m) vs LA (760 m)High Altitude Pulmonary HypertensionNCT06489704University of Zurich24
进行中（未招募）
不适用
HA Residents With PVD, SDB Assessed at HA (2840m) vs LA (Sea Level)Pulmonary Vascular DiseasePulmonary Artery HypertensionChronic Thromboembolic Pulmonary HypertensionNCT06072417University of Zurich24
Unknown
4 期
Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Breathing and SleepPrecapillary Pulmonary HypertensionInterstitial Lung DiseaseNCT02150616University of Zurich50
已完成
4 期
Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Exercise PerformancePrecapillary Pulmonary HypertensionInterstitial Lung DiseaseNCT02143687University of Zurich30